25 XP   0   0   10

HCW Biologics Inc
Buy, Hold or Sell?

Let's analyse HCW Biologics Inc together

PenkeI guess you are interested in HCW Biologics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of HCW Biologics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about HCW Biologics Inc

I send you an email if I find something interesting about HCW Biologics Inc.

Quick analysis of HCW Biologics Inc (30 sec.)










What can you expect buying and holding a share of HCW Biologics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
14.3%

What is your share worth?

Current worth
$0.36
Expected worth in 1 year
$-0.15
How sure are you?
21.4%

+ What do you gain per year?

Total Gains per Share
$-0.51
Return On Investment
-31.3%

For what price can you sell your share?

Current Price per Share
$1.62
Expected price per share
$1.79 - $1.75
How sure are you?
50%

1. Valuation of HCW Biologics Inc (5 min.)




Live pricePrice per Share (EOD)

$1.62

Intrinsic Value Per Share

$-11.94 - $-14.12

Total Value Per Share

$-11.58 - $-13.77

2. Growth of HCW Biologics Inc (5 min.)




Is HCW Biologics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$13.4m$39.6m-$19.8m-100.0%

How much money is HCW Biologics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$7.6m-$4.3m-$3.2m-42.7%
Net Profit Margin-720.9%-3,255.0%--

How much money comes from the company's main activities?

3. Financial Health of HCW Biologics Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#647 / 1019

Most Revenue
#503 / 1019

Most Profit
#505 / 1019

Most Efficient
#786 / 1019

What can you expect buying and holding a share of HCW Biologics Inc? (5 min.)

Welcome investor! HCW Biologics Inc's management wants to use your money to grow the business. In return you get a share of HCW Biologics Inc.

What can you expect buying and holding a share of HCW Biologics Inc?

First you should know what it really means to hold a share of HCW Biologics Inc. And how you can make/lose money.

Speculation

The Price per Share of HCW Biologics Inc is $1.62. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of HCW Biologics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in HCW Biologics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.36. Based on the TTM, the Book Value Change Per Share is $-0.13 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.11 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of HCW Biologics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.28-17.5%-0.20-12.5%-0.12-7.3%-0.12-7.3%-0.12-7.3%
Usd Book Value Change Per Share0.000.0%-0.13-7.8%-0.11-6.9%0.031.6%0.031.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.010.3%0.010.3%
Usd Total Gains Per Share0.000.0%-0.13-7.8%-0.11-6.9%0.031.9%0.031.9%
Usd Price Per Share1.75-1.76-1.95-1.65-1.65-
Price to Earnings Ratio-1.55--2.76--4.35--3.94--3.94-
Price-to-Total Gains Ratio-13.32--18.69-2,244.96-2,244.96-
Price to Book Ratio4.91-3.55-1.85-1.97-1.97-
Price-to-Total Gains Ratio-13.32--18.69-2,244.96-2,244.96-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.62
Number of shares617
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share-0.130.03
Usd Total Gains Per Share-0.130.03
Gains per Quarter (617 shares)-78.2619.12
Gains per Year (617 shares)-313.0376.49
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-313-323146366
20-626-63627126142
30-939-94941189218
40-1252-126255251294
50-1565-157568314370
60-1878-188882377446
70-2191-220196440522
80-2504-2514109503598
90-2817-2827123566674
100-3130-3140136628750

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%1.013.00.07.1%1.013.00.07.1%1.013.00.07.1%
Book Value Change Per Share0.03.01.00.0%1.010.01.08.3%2.011.01.014.3%2.011.01.014.3%2.011.01.014.3%
Dividend per Share0.00.04.00.0%2.00.010.016.7%2.00.012.014.3%2.00.012.014.3%2.00.012.014.3%
Total Gains per Share0.03.01.00.0%2.09.01.016.7%3.010.01.021.4%3.010.01.021.4%3.010.01.021.4%

Fundamentals of HCW Biologics Inc

About HCW Biologics Inc

HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as pulmonary fibrosis; and HCW9302 for auto-immune diseases, such as alopecia areata and metabolic diseases. It also develops HCW9201, a cell-based therapy that is in Phase II clinical trials for the treatment of patients with relapsed/refractory acute myeloid leukemia; and HCW9206 for the treatment of acute myeloid leukemia. HCW Biologics Inc. was incorporated in 2018 and is headquartered in Miramar, Florida.

Fundamental data was last updated by Penke on 2024-04-11 10:38:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of HCW Biologics Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit HCW Biologics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare HCW Biologics Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -806.7% means that $-8.07 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of HCW Biologics Inc:

  • The MRQ is -806.7%. The company is making a huge loss. -2
  • The TTM is -720.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-806.7%TTM-720.9%-85.8%
TTM-720.9%YOY-3,255.0%+2,534.1%
TTM-720.9%5Y-1,137.5%+416.6%
5Y-1,137.5%10Y-1,137.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-806.7%-196.9%-609.8%
TTM-720.9%-211.2%-509.7%
YOY-3,255.0%-279.3%-2,975.7%
5Y-1,137.5%-436.8%-700.7%
10Y-1,137.5%-599.3%-538.2%
1.1.2. Return on Assets

Shows how efficient HCW Biologics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare HCW Biologics Inc to the Biotechnology industry mean.
  • -37.5% Return on Assets means that HCW Biologics Inc generated $-0.37 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of HCW Biologics Inc:

  • The MRQ is -37.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -24.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-37.5%TTM-24.9%-12.5%
TTM-24.9%YOY-9.4%-15.6%
TTM-24.9%5Y-13.2%-11.7%
5Y-13.2%10Y-13.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-37.5%-13.6%-23.9%
TTM-24.9%-12.9%-12.0%
YOY-9.4%-11.9%+2.5%
5Y-13.2%-14.2%+1.0%
10Y-13.2%-16.2%+3.0%
1.1.3. Return on Equity

Shows how efficient HCW Biologics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare HCW Biologics Inc to the Biotechnology industry mean.
  • -79.3% Return on Equity means HCW Biologics Inc generated $-0.79 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of HCW Biologics Inc:

  • The MRQ is -79.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -48.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-79.3%TTM-48.6%-30.7%
TTM-48.6%YOY-11.4%-37.2%
TTM-48.6%5Y-21.4%-27.2%
5Y-21.4%10Y-21.4%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-79.3%-17.0%-62.3%
TTM-48.6%-16.1%-32.5%
YOY-11.4%-15.4%+4.0%
5Y-21.4%-20.0%-1.4%
10Y-21.4%-21.1%-0.3%

1.2. Operating Efficiency of HCW Biologics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient HCW Biologics Inc is operating .

  • Measures how much profit HCW Biologics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare HCW Biologics Inc to the Biotechnology industry mean.
  • An Operating Margin of -813.3% means the company generated $-8.13  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of HCW Biologics Inc:

  • The MRQ is -813.3%. The company is operating very inefficient. -2
  • The TTM is -514.2%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-813.3%TTM-514.2%-299.1%
TTM-514.2%YOY-3,559.1%+3,044.9%
TTM-514.2%5Y-1,164.5%+650.3%
5Y-1,164.5%10Y-1,164.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-813.3%-282.4%-530.9%
TTM-514.2%-225.8%-288.4%
YOY-3,559.1%-288.4%-3,270.7%
5Y-1,164.5%-475.2%-689.3%
10Y-1,164.5%-624.7%-539.8%
1.2.2. Operating Ratio

Measures how efficient HCW Biologics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 9.13 means that the operating costs are $9.13 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of HCW Biologics Inc:

  • The MRQ is 9.133. The company is inefficient in keeping operating costs low. -1
  • The TTM is 8.567. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ9.133TTM8.567+0.566
TTM8.567YOY36.542-27.975
TTM8.5675Y13.039-4.471
5Y13.03910Y13.0390.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.1332.994+6.139
TTM8.5673.247+5.320
YOY36.5423.766+32.776
5Y13.0395.675+7.364
10Y13.0397.857+5.182

1.3. Liquidity of HCW Biologics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if HCW Biologics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.73 means the company has $0.73 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of HCW Biologics Inc:

  • The MRQ is 0.732. The company is unable to pay all its short-term debts. -2
  • The TTM is 2.096. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ0.732TTM2.096-1.364
TTM2.096YOY15.230-13.134
TTM2.0965Y10.964-8.868
5Y10.96410Y10.9640.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7323.930-3.198
TTM2.0964.251-2.155
YOY15.2305.436+9.794
5Y10.9646.045+4.919
10Y10.9646.383+4.581
1.3.2. Quick Ratio

Measures if HCW Biologics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare HCW Biologics Inc to the Biotechnology industry mean.
  • A Quick Ratio of 0.59 means the company can pay off $0.59 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of HCW Biologics Inc:

  • The MRQ is 0.587. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 2.288. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ0.587TTM2.288-1.701
TTM2.288YOY19.455-17.167
TTM2.2885Y14.039-11.751
5Y14.03910Y14.0390.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5873.629-3.042
TTM2.2884.065-1.777
YOY19.4555.390+14.065
5Y14.0395.993+8.046
10Y14.0396.277+7.762

1.4. Solvency of HCW Biologics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of HCW Biologics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare HCW Biologics Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.53 means that HCW Biologics Inc assets are financed with 52.8% credit (debt) and the remaining percentage (100% - 52.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of HCW Biologics Inc:

  • The MRQ is 0.528. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.415. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.528TTM0.415+0.112
TTM0.415YOY0.162+0.253
TTM0.4155Y0.208+0.207
5Y0.20810Y0.2080.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5280.332+0.196
TTM0.4150.333+0.082
YOY0.1620.268-0.106
5Y0.2080.366-0.158
10Y0.2080.390-0.182
1.4.2. Debt to Equity Ratio

Measures if HCW Biologics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare HCW Biologics Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 111.8% means that company has $1.12 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of HCW Biologics Inc:

  • The MRQ is 1.118. The company is able to pay all its debts with equity. +1
  • The TTM is 0.777. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ1.118TTM0.777+0.341
TTM0.777YOY0.205+0.573
TTM0.7775Y0.336+0.441
5Y0.33610Y0.3360.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1180.380+0.738
TTM0.7770.389+0.388
YOY0.2050.334-0.129
5Y0.3360.432-0.096
10Y0.3360.465-0.129

2. Market Valuation of HCW Biologics Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings HCW Biologics Inc generates.

  • Above 15 is considered overpriced but always compare HCW Biologics Inc to the Biotechnology industry mean.
  • A PE ratio of -1.55 means the investor is paying $-1.55 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of HCW Biologics Inc:

  • The EOD is -1.432. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.547. Based on the earnings, the company is expensive. -2
  • The TTM is -2.755. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.432MRQ-1.547+0.115
MRQ-1.547TTM-2.755+1.208
TTM-2.755YOY-4.346+1.591
TTM-2.7555Y-3.942+1.187
5Y-3.94210Y-3.9420.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.432-2.426+0.994
MRQ-1.547-2.552+1.005
TTM-2.755-2.656-0.099
YOY-4.346-4.143-0.203
5Y-3.942-6.252+2.310
10Y-3.942-6.108+2.166
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of HCW Biologics Inc:

  • The EOD is -2.009. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.171. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.111. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.009MRQ-2.171+0.161
MRQ-2.171TTM-2.111-0.059
TTM-2.111YOY-4.365+2.254
TTM-2.1115Y-3.870+1.759
5Y-3.87010Y-3.8700.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.009-3.199+1.190
MRQ-2.171-3.259+1.088
TTM-2.111-3.552+1.441
YOY-4.365-5.617+1.252
5Y-3.870-8.326+4.456
10Y-3.870-8.689+4.819
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of HCW Biologics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 4.91 means the investor is paying $4.91 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of HCW Biologics Inc:

  • The EOD is 4.544. Based on the equity, the company is fair priced.
  • The MRQ is 4.909. Based on the equity, the company is fair priced.
  • The TTM is 3.554. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD4.544MRQ4.909-0.365
MRQ4.909TTM3.554+1.354
TTM3.554YOY1.846+1.708
TTM3.5545Y1.974+1.581
5Y1.97410Y1.9740.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD4.5441.947+2.597
MRQ4.9092.116+2.793
TTM3.5542.095+1.459
YOY1.8462.836-0.990
5Y1.9743.443-1.469
10Y1.9743.791-1.817
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of HCW Biologics Inc.

3.1. Institutions holding HCW Biologics Inc

Institutions are holding 2.971% of the shares of HCW Biologics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Vanguard Group Inc0.543302051425230.2556
2023-12-31HighTower Advisors, LLC0.47620.0004179810-175059-49.3306
2023-12-31Honkamp Krueger Financial Services Inc0.47550.00841795411795410
2023-12-31Geode Capital Management, LLC0.356013443619331.4588
2023-12-31Cresset Asset Management, LLC0.34950.00113199000
2023-12-31Bridgeway Capital Management, LLC0.22430.00228470021002.5424
2023-12-31BlackRock Inc0.1249047158-562-1.1777
2023-12-31AE Wealth Management LLC0.07940.000230000300000
2023-12-31Two Sigma Investments LLC0.060.000122640-200-0.8757
2023-12-31State Street Corporation0.056802144600
2023-12-31Northern Trust Corp0.02701020500
2023-12-31Tower Research Capital LLC0.0150.00015669100521.548
2023-12-31Focused Wealth Strategies, INC.0.00260.0002100000
2023-12-31UBS Group AG0.00170635423199.5283
2023-12-31Royal Bank of Canada0.000802962960
2023-12-31Wells Fargo & Co0.0004013875.3435
2023-12-31JPMorgan Chase & Co0.000208361277.2727
2023-12-31Bank of America Corp0011110
Total 2.79360.01261054900+40079+3.8%

3.2. Funds holding HCW Biologics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv0.4475016925013090.7794
2023-12-31Bridgeway Ultra-Small Company Market0.22390.05588470021002.5424
2024-02-29Fidelity Extended Market Index0.1790.000367710-328-0.4821
2024-03-28iShares Micro-Cap ETF0.11280.00784265200
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.0990.00013745100
2024-02-29Fidelity Total Market Index0.07670.00012902300
2024-02-29Fidelity Nasdaq Composite Index0.06150.00022327200
2023-12-31Northern Trust Extended Eq Market Idx0.0240.0002906000
2023-12-31NT Ext Equity Mkt Idx Fd - L0.0240.0002906000
2024-02-29Fidelity Series Total Market Index0.02050775200
2024-02-29Spartan Total Market Index Pool E0.00950359300
2024-02-291290 VT Micro Cap K0.00890.0034338200
2023-09-30ZWJ Balanced0.00830.0004312531250
2024-03-31State St US Extended Mkt Indx NL Cl C0.00790.0003300000
2023-12-31SSgA U.S. Extended Market Index Class I0.00790.0001300000
2024-02-29Spartan Extended Market Index Pool E0.00780.0002295432812.4905
2023-12-31Northern Trust Wilshire 50000.0030114500
2023-12-31NT US Market Cap Idx Fd - L0.0030114500
2024-02-29State St US Ttl Mkt Indx SL Cl I0.0024090000
2023-12-31SSgA U.S. Total Market Index Strategy0.00230865-20-2.2599
Total 1.32990.0691503039+6514+1.3%

3.3. Insider Transactions

Insiders are holding 54.72% of the shares of HCW Biologics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-09-14Hing C WongBUY18002.08
2023-09-13Gary M WinerBUY5462.05
2023-09-13Rebecca ByamBUY50002.1
2023-09-11Gary M WinerBUY992.05
2023-09-11Rebecca ByamBUY50002.05
2023-09-08Rebecca ByamBUY50002.02
2023-09-07Gary M WinerBUY631.95
2023-09-06Rebecca ByamBUY50001.95
2023-09-05Gary M WinerBUY4001.75
2023-06-09Rebecca ByamBUY200002.06
2023-06-08Lee FlowersBUY100002.16
2023-06-07Rebecca ByamBUY200002.03
2023-06-05Rebecca ByamBUY200001.67
2023-06-01Hing C WongBUY8001.62
2023-05-30Gary M WinerBUY8501.52
2023-05-30Hing C WongBUY30001.55
2023-05-26Rebecca ByamBUY200001.66
2023-05-24Rebecca ByamBUY200001.61
2023-05-22Rebecca ByamBUY334501.53

4. Summary

4.1. Key Performance Indicators

The key performance indicators of HCW Biologics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share----0.1270%-0.1110%0.025-100%0.025-100%
Book Value Per Share--0.3570.526-32%1.051-66%0.809-56%0.809-56%
Current Ratio--0.7322.096-65%15.230-95%10.964-93%10.964-93%
Debt To Asset Ratio--0.5280.415+27%0.162+226%0.208+153%0.208+153%
Debt To Equity Ratio--1.1180.777+44%0.205+446%0.336+233%0.336+233%
Dividend Per Share----0%-0%0.006-100%0.006-100%
Eps---0.283-0.203-28%-0.119-58%-0.118-58%-0.118-58%
Free Cash Flow Per Share---0.202-0.214+6%-0.152-24%-0.135-33%-0.135-33%
Free Cash Flow To Equity Per Share---0.202-0.215+6%-0.111-45%-0.020-90%-0.020-90%
Gross Profit Margin--1.4731.118+32%1.000+47%1.034+43%1.034+43%
Intrinsic Value_10Y_max---14.124--------
Intrinsic Value_10Y_min---11.937--------
Intrinsic Value_1Y_max---0.708--------
Intrinsic Value_1Y_min---0.695--------
Intrinsic Value_3Y_max---2.666--------
Intrinsic Value_3Y_min---2.534--------
Intrinsic Value_5Y_max---5.274--------
Intrinsic Value_5Y_min---4.849--------
Market Cap61171686.000-8%66080525.00066505328.375-1%73689225.450-10%62280220.521+6%62280220.521+6%
Net Profit Margin---8.067-7.209-11%-32.550+304%-11.375+41%-11.375+41%
Operating Margin---8.133-5.142-37%-35.591+338%-11.645+43%-11.645+43%
Operating Ratio--9.1338.567+7%36.542-75%13.039-30%13.039-30%
Pb Ratio4.544-8%4.9093.554+38%1.846+166%1.974+149%1.974+149%
Pe Ratio-1.432+7%-1.547-2.755+78%-4.346+181%-3.942+155%-3.942+155%
Price Per Share1.620-8%1.7501.761-1%1.952-10%1.649+6%1.649+6%
Price To Free Cash Flow Ratio-2.009+7%-2.171-2.111-3%-4.365+101%-3.870+78%-3.870+78%
Quick Ratio--0.5872.288-74%19.455-97%14.039-96%14.039-96%
Return On Assets---0.375-0.249-33%-0.094-75%-0.132-65%-0.132-65%
Return On Equity---0.793-0.486-39%-0.114-86%-0.214-73%-0.214-73%
Total Gains Per Share----0.1270%-0.1110%0.031-100%0.031-100%
Usd Book Value--13461717.00019844002.250-32%39692022.250-66%30542112.286-56%30542112.286-56%
Usd Book Value Change Per Share----0.1270%-0.1110%0.025-100%0.025-100%
Usd Book Value Per Share--0.3570.526-32%1.051-66%0.809-56%0.809-56%
Usd Dividend Per Share----0%-0%0.006-100%0.006-100%
Usd Eps---0.283-0.203-28%-0.119-58%-0.118-58%-0.118-58%
Usd Free Cash Flow---7610442.000-8097141.250+6%-5746030.000-24%-5113209.214-33%-5113209.214-33%
Usd Free Cash Flow Per Share---0.202-0.214+6%-0.152-24%-0.135-33%-0.135-33%
Usd Free Cash Flow To Equity Per Share---0.202-0.215+6%-0.111-45%-0.020-90%-0.020-90%
Usd Market Cap61171686.000-8%66080525.00066505328.375-1%73689225.450-10%62280220.521+6%62280220.521+6%
Usd Price Per Share1.620-8%1.7501.761-1%1.952-10%1.649+6%1.649+6%
Usd Profit---10680531.000-7651030.750-28%-4384786.500-59%-4369895.429-59%-4369895.429-59%
Usd Revenue--1324002.0001030978.250+28%911607.000+45%1070545.429+24%1070545.429+24%
Usd Total Gains Per Share----0.1270%-0.1110%0.031-100%0.031-100%
 EOD+2 -5MRQTTM+9 -20YOY+6 -235Y+8 -2710Y+8 -27

4.2. Fundamental Score

Let's check the fundamental score of HCW Biologics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.432
Price to Book Ratio (EOD)Between0-14.544
Net Profit Margin (MRQ)Greater than0-8.067
Operating Margin (MRQ)Greater than0-8.133
Quick Ratio (MRQ)Greater than10.587
Current Ratio (MRQ)Greater than10.732
Debt to Asset Ratio (MRQ)Less than10.528
Debt to Equity Ratio (MRQ)Less than11.118
Return on Equity (MRQ)Greater than0.15-0.793
Return on Assets (MRQ)Greater than0.05-0.375
Total1/10 (10.0%)

4.3. Technical Score

Let's check the technical score of HCW Biologics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.317
Ma 20Greater thanMa 501.665
Ma 50Greater thanMa 1001.472
Ma 100Greater thanMa 2001.306
OpenGreater thanClose1.930
Total4/5 (80.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-03-312023-06-302023-09-302023-12-312024-03-31
Gross Profit  131081205417578253-275-22



Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets28,514
Total Liabilities15,052
Total Stockholder Equity13,462
 As reported
Total Liabilities 15,052
Total Stockholder Equity+ 13,462
Total Assets = 28,514

Assets

Total Assets28,514
Total Current Assets6,404
Long-term Assets22,109
Total Current Assets
Cash And Cash Equivalents 3,595
Net Receivables 1,536
Other Current Assets 1,273
Total Current Assets  (as reported)6,404
Total Current Assets  (calculated)6,404
+/-0
Long-term Assets
Property Plant Equipment 20,453
Long-term Assets Other 57
Long-term Assets  (as reported)22,109
Long-term Assets  (calculated)20,510
+/- 1,600

Liabilities & Shareholders' Equity

Total Current Liabilities8,748
Long-term Liabilities6,304
Total Stockholder Equity13,462
Total Current Liabilities
Short-term Debt 147
Accounts payable 6,167
Other Current Liabilities 2,433
Total Current Liabilities  (as reported)8,748
Total Current Liabilities  (calculated)8,748
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)6,304
Long-term Liabilities  (calculated)0
+/- 6,304
Total Stockholder Equity
Common Stock4
Retained Earnings -70,532
Other Stockholders Equity 83,990
Total Stockholder Equity (as reported)13,462
Total Stockholder Equity (calculated)13,462
+/-0
Other
Cash and Short Term Investments 3,595
Common Stock Shares Outstanding 35,996
Liabilities and Stockholders Equity 28,514
Net Debt 2,857
Net Working Capital -2,343
Short Long Term Debt Total 6,452



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
> Total Assets 
0
0
0
15,398
12,928
13,033
56,406
53,515
50,956
47,408
51,353
46,809
43,535
39,483
35,616
28,514
28,514
28,51428,51435,61639,48343,53546,80951,35347,40850,95653,51556,40613,03312,92815,398000
   > Total Current Assets 
0
0
0
12,149
9,799
10,046
43,559
40,480
37,906
34,628
28,708
34,071
29,940
19,799
13,848
6,404
6,404
6,4046,40413,84819,79929,94034,07128,70834,62837,90640,48043,55910,0469,79912,149000
       Cash And Cash Equivalents 
0
0
0
8,456
6,856
5,051
15,125
11,731
18,117
15,420
26,224
22,326
18,390
7,449
11,221
3,595
3,595
3,5953,59511,2217,44918,39022,32626,22415,42018,11711,73115,1255,0516,8568,456000
       Short-term Investments 
0
0
0
0
0
1,600
24,990
24,984
16,969
16,994
0
9,736
9,848
9,959
0
0
0
0009,9599,8489,736016,99416,96924,98424,9901,60000000
       Net Receivables 
0
0
0
2,500
1,300
50
70
133
553
347
356
418
253
707
710
1,536
1,536
1,5361,53671070725341835634755313370501,3002,500000
       Other Current Assets 
0
0
0
655
860
894
1,383
1,437
246
470
206
196
317
327
175
231
1,273
1,2732311753273171962064702461,4371,383894860655000
   > Long-term Assets 
0
0
0
3,249
3,129
2,987
12,847
13,034
13,050
12,780
22,645
12,738
13,594
19,684
21,768
22,109
22,109
22,10922,10921,76819,68413,59412,73822,64512,78013,05013,03412,8472,9873,1293,249000
       Property Plant Equipment 
0
0
0
1,615
1,529
1,387
1,269
1,119
1,012
914
10,958
10,805
11,741
12,623
14,781
20,453
20,453
20,45320,45314,78112,62311,74110,80510,9589141,0121,1191,2691,3871,5291,615000
       Long Term Investments 
0
0
0
1,600
1,600
1,600
11,578
11,522
11,351
11,303
11,269
1,600
1,600
1,600
1,600
1,600
0
01,6001,6001,6001,6001,60011,26911,30311,35111,52211,5781,6001,6001,600000
       Other Assets 
0
0
0
0
0
0
0
393
686
564
419
334
0
5,350
0
0
0
0005,35003344195646863930000000
> Total Liabilities 
0
0
0
1,001
1,347
4,169
2,395
2,322
1,557
1,243
8,798
9,381
10,916
10,898
11,749
15,052
15,052
15,05215,05211,74910,89810,9169,3818,7981,2431,5572,3222,3954,1691,3471,001000
   > Total Current Liabilities 
0
0
0
1,001
1,347
4,169
2,395
2,322
1,417
1,145
2,293
2,956
4,522
4,538
5,417
8,748
8,748
8,7488,7485,4174,5384,5222,9562,2931,1451,4172,3222,3954,1691,3471,001000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
6,448
6,410
146
0
0
0
147
1470001466,4106,4480000000000
       Accounts payable 
0
0
0
155
323
997
637
224
743
296
1,410
1,226
1,165
2,116
3,154
6,167
6,167
6,1676,1673,1542,1161,1651,2261,410296743224637997323155000
       Other Current Liabilities 
0
0
0
846
1,023
3,173
1,757
2,098
674
848
883
1,730
3,357
2,422
2,263
0
2,433
2,43302,2632,4223,3571,7308838486742,0981,7573,1731,023846000
   > Long-term Liabilities 
0
0
0
0
0
8,864
0
224
140
98
6,505
6,424
6,394
6,360
6,333
6,304
6,304
6,3046,3046,3336,3606,3946,4246,5059814022408,86400000
       Other Liabilities 
0
0
0
0
0
0
0
0
140
98
57
0
0
0
0
0
0
000000579814000000000
> Total Stockholder Equity
0
0
0
14,397
11,581
8,864
54,011
51,193
49,399
46,165
42,555
37,429
32,619
28,586
23,867
13,462
13,462
13,46213,46223,86728,58632,61937,42942,55546,16549,39951,19354,0118,86411,58114,397000
   Common Stock
0
0
0
0
0
0
4
4
4
4
4
4
4
4
4
0
4
40444444444000000
   Retained Earnings Total Equity0000-50,609-45,538-40,119-36,205000000000
   Accumulated Other Comprehensive Income 0000000000-56,406-23,24000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
82,367
82,671
82,963
83,224
0
0
0
0
000083,22482,96382,67182,367000000000
   Treasury Stock00000000000000000
   Other Stockholders Equity 
0
0
0
0
0
23,240
81,472
81,827
82,090
82,367
82,671
82,963
83,224
83,495
83,715
0
83,990
83,990083,71583,49583,22482,96382,67182,36782,09081,82781,47223,24000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue2,842
Cost of Revenue-3,417
Gross Profit-575-575
 
Operating Income (+$)
Gross Profit-575
Operating Expense-25,142
Operating Income-25,717-25,717
 
Operating Expense (+$)
Research Development7,135
Selling General Administrative13,084
Selling And Marketing Expenses4,656
Operating Expense25,14224,876
 
Net Interest Income (+$)
Interest Income0
Interest Expense-283
Other Finance Cost-96
Net Interest Income-379
 
Pretax Income (+$)
Operating Income-25,717
Net Interest Income-379
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-24,994-26,440
EBIT - interestExpense = -26,000
-24,994
-24,711
Interest Expense283
Earnings Before Interest and Taxes (EBIT)-25,717-24,711
Earnings Before Interest and Taxes (EBITDA)-24,582
 
After tax Income (+$)
Income Before Tax-24,994
Tax Provision-0
Net Income From Continuing Ops-19,732-24,994
Net Income-24,994
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses28,559
Total Other Income/Expenses Net723379
 

Technical Analysis of HCW Biologics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of HCW Biologics Inc. The general trend of HCW Biologics Inc is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine HCW Biologics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of HCW Biologics Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 1.75 < 1.75 < 1.75.

The bearish price targets are: 1.9 > 1.8199 > 1.79.

Tweet this
HCW Biologics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of HCW Biologics Inc. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

HCW Biologics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of HCW Biologics Inc. The current macd is 0.02502368.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the HCW Biologics Inc price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for HCW Biologics Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the HCW Biologics Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
HCW Biologics Inc Daily Moving Average Convergence/Divergence (MACD) ChartHCW Biologics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of HCW Biologics Inc. The current adx is 24.22.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy HCW Biologics Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
HCW Biologics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of HCW Biologics Inc. The current sar is 1.5001.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
HCW Biologics Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of HCW Biologics Inc. The current rsi is 52.32. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
HCW Biologics Inc Daily Relative Strength Index (RSI) ChartHCW Biologics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of HCW Biologics Inc. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the HCW Biologics Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
HCW Biologics Inc Daily Stochastic Oscillator ChartHCW Biologics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of HCW Biologics Inc. The current cci is 29.80.

HCW Biologics Inc Daily Commodity Channel Index (CCI) ChartHCW Biologics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of HCW Biologics Inc. The current cmo is 0.62046943.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
HCW Biologics Inc Daily Chande Momentum Oscillator (CMO) ChartHCW Biologics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of HCW Biologics Inc. The current willr is -72.09302326.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that HCW Biologics Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
HCW Biologics Inc Daily Williams %R ChartHCW Biologics Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of HCW Biologics Inc.

HCW Biologics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of HCW Biologics Inc. The current atr is 0.14376142.

HCW Biologics Inc Daily Average True Range (ATR) ChartHCW Biologics Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of HCW Biologics Inc. The current obv is -672,836.

HCW Biologics Inc Daily On-Balance Volume (OBV) ChartHCW Biologics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of HCW Biologics Inc. The current mfi is 58.68.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
HCW Biologics Inc Daily Money Flow Index (MFI) ChartHCW Biologics Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for HCW Biologics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-27ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-04ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

HCW Biologics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of HCW Biologics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.317
Ma 20Greater thanMa 501.665
Ma 50Greater thanMa 1001.472
Ma 100Greater thanMa 2001.306
OpenGreater thanClose1.930
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of HCW Biologics Inc with someone you think should read this too:
  • Are you bullish or bearish on HCW Biologics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about HCW Biologics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about HCW Biologics Inc

I send you an email if I find something interesting about HCW Biologics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about HCW Biologics Inc.

Receive notifications about HCW Biologics Inc in your mailbox!